1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biosimilars Business Review Q1 2015

Biosimilars Business Review Q1 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 32 pages

Industry Trend Analysis - Zarxio's Approval Will See Focus Shift To Battle For Market Acceptance
Industry Brief - Apotex' Pegfilgrastim Biosimilar Accepted By FDA
Industry Brief - FDA Approves Teva's Filgrastim For Self-Administration
Industry Brief - Torrent And Reliance Life Sciences Enter India Biosimilars Agreement
Industry Trend Analysis - US Approval Of Sandoz' Filgrastim Advances With Small Steps, Not Giant Leaps
Industry Brief - Hospira Files US Epoetin Alfa Biosimilar Application
Industry Brief - NICE Updates Biosimilars Guidance
Industry Brief - EMA Accepts Samsung Bioepis' Etanercept Biosimilar For Review
Industry Trend Analysis - As Biosimilar Adalimumab Progresses, Amgen And AbbVie's Fortunes Cast In Comparative Light
Industry Trend Analysis - Acquisition Of Hospira Gives Pfizer Entrance To Biosimilar And Medical Device Markets
Industry Trend Analysis - State Biosimilar Legislation Continues To Divide; Language Will Determine Commercial Success
Industry Trend Analysis - Hospira Eyes Up Lucentis Biosimilar In Deal That Will Threaten Roche/Novartis
Industry Brief - Oncobiologics' Adalimumab Biosimilar Meets Primary Endpoint
Industry Trend Analysis - FDA Budget Request Signals Reopening Of Labelling Debate
Industry Brief - Hospira Launches Inflectra In Remaining European Countries
Industry Brief - Apotex' Second Biosimilar Application Accepted By FDA
Industry Brief - Use Of Biosimilar Infliximab Could Produce Significant CD Savings
Industry Trend Analysis - Roche Most At Risk From Upcoming Biosimilar Oncology Market
Industry Brief - Celltrion Launches Remsima In Europe
Industry Brief - Samsung Bioepis Submits Infliximab MAA To EMA

Table Of Contents

Biosimilars Business Review Q1 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...

Global Biosimilar Drug Market Research Report 2016

Global Biosimilar Drug Market Research Report 2016

  • $ 2850
  • Industry report
  • November 2016
  • by 9Dimen Research

2016 Global Biosimilar Drug Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Biosimilar Drug industry, focusing on the main regions ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.